Study Stopped
Resource constraints at participating sites
Sepsis Assessment in Belgian Emergency Rooms
SABER
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein Assay to Assist in Evaluation of Patients With Suspected Infection Following Emergency Department Admission
1 other identifier
observational
100
1 country
4
Brief Summary
To validate the use of the Heparin Binding Protein (HBP) concentration to assist in the evaluation of patients admitting to the emergency department with suspected infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2015
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2015
CompletedFirst Posted
Study publicly available on registry
April 23, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJanuary 9, 2019
January 1, 2019
3.6 years
April 15, 2015
January 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Validation of use of HBP in evaluation of patients with suspected infection
12 months
Eligibility Criteria
Patients presenting to the Emergency Department with suspected infection
You may qualify if:
- \>18 years of age,
- Suspected infection (temperature \>38C or clinical evidence of infection),
- intention by clinician to start antibiotics
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Clinique St Anne St Remy
Anderlecht, 1070, Belgium
Hopital Erasme
Brussels, 1070, Belgium
Hopital Civil de Charleroi
Charleroi, 6000, Belgium
CHU Tivoli
La Louvière, 7100, Belgium
Biospecimen
Plasma - NaCitrate and LiHep
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Louis Vincent, MD
Erasme University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2015
First Posted
April 23, 2015
Study Start
May 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
January 9, 2019
Record last verified: 2019-01